SEARCH · Engineering Papers

Results for “Biological databases”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

SourceResearch connectionFrom yearThrough year

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 91 records · Page 5

All sources NASA NTRS DOE OSTI

NASA NTRS2018

FAIRness and Usability for Open-Access Omics Data Systems

Omics data sharing is especially crucial to the biological research community, and the last decade or two has seen a huge rise in collaborative analysis systems, databases, and knowledge bases for omics and other systems biology data. We assessed the "FAIRness" of NASA's GeneLab Data Systems (GLDS) along with four similar kinds of systems in the research omics data domain, using 14 FAIRness metrics. 14 metrics. The range of Pass ratings was 29-79% of the 14 metrics, Partial Pass 0-21%, and Fail 7-50%. The range of overall FAIRness scores was 5-12 (out of 14). The systems we evaluated performed the best in the areas of data findability and accessibility, and worst in the area of data interoperability. We propose two new principles that Big Data systems, in particular, should consider for increasing data accessibility. We relate our experiences implementing semantic integration of omics data from several systems for the federated querying and retrieval functions of the GLDS, given the shortcomings in data interoperability of these systems.

Berrios, Daniel C.↗

NASA NTRS2018

FAIRness and Usability for Open-access Omics Data Systems

Omics data sharing is crucial to the biological research community, and the last decade or two has seen a huge rise in collaborative analysis systems, databases, and knowledge bases for omics and other systems biology data. We assessed the "FAIRness" of NASA's GeneLab Data Systems (GLDS) along with four similar kinds of systems in the research omics data domain, using 14 FAIRness metrics. The range of overall FAIRness scores was 6-12 (out of 14), average 10.1, and standard deviation 2.4. The range of Pass ratings for the metrics was 29-79%, Partial Pass 0-21%, and Fail 7-50%. The systems we evaluated performed the best in the areas of data findability and accessibility, and worst in the area of data interoperability. Reusability of metadata, in particular, was frequently not well supported. We relate our experiences implementing semantic integration of omics data from some of the assessed systems for federated querying and retrieval functions, given their shortcomings in data interoperability. Finally, we propose two new principles that Big Data system developers, in particular, should consider for maximizing data accessibility.

Berrios, Daniel C.↗

NASA NTRS2018

FAIRness and Usability for Open-access Omics Data Systems

Omics data sharing is crucial to the biological research community, and the last decade or two has seen a huge rise in collaborative analysis systems, databases, and knowledge bases for omics and other systems biology data. We assessed the “FAIRness” of NASA’s GeneLab Data Systems (GLDS) along with four similar kinds of systems in the research omics data domain, using 14 FAIRness metrics. The range of overall FAIRness scores was 6-12 (out of 14), average 10.1, and standard deviation 2.4. The range of Pass ratings for the metrics was 29-79%, Partial Pass 0-21%, and Fail 7-50%. The systems we evaluated performed the best in the areas of data findability and accessibility, and worst in the area of data interoperability. Reusability of metadata, in particular, was frequently not well supported. We relate our experiences implementing semantic integration of omics data from some of the assessed systems for federated querying and retrieval functions, given their shortcomings in data interoperability. Finally, we propose two new principles that Big Data system developers, in particular, should consider for maximizing data accessibility.

Berrios, Daniel C.↗

NASA NTRSDate not supplied

New developments in space radiation research at NASA: Annotating data using a novel radiation biology ontology

Like many interdisciplinary sciences, data producers and consumers in the field of radiation biology often use a wide variety of terminology to describe their experiments and data. Furthermore, space systems and technologies are rapidly evolving, and a shared understanding and common terminology for these is also lacking. The efficiency of research organizations can be enhanced by standardizing metadata through the use of knowledge resources like ontologies. Employing a sophisticated model such as a formal ontology to standardize metadata enables automated data acquisition processes and supports more complete, accurate meta-analysis through more efficient and complete data discovery and retrieval, particularly when using multiple data sources. Thus, we developed the Radiation Biology Ontology (RBO) in order to improved radiation biology metadata uniformity and transparency. We used open-source software (the Ontology Development Kit, Protégé and WebProtégé) and worked within the OBO Foundry framework, which includes a set of ontology development principles and practices for ontology consistency, uniformity, and accountability. The RBO has now been incorporated into two radiation research data repositories, NASA’s GeneLab omics database (https://genelab.nasa.gov), and the European Commission STORE database (https://www.storedb.org/). Continuous build integration tools allowed our international RBO collaboration to be more efficient and focus its efforts on semantic model design. Currently, the RBO contains over 300 annotated classes and individuals specific to the study of radiation on biological systems, as well as imports of many additional classes from other OBO Foundry ontologies that relate to and/or provide context for these RBO entities. We publish the RBO through the OBO Foundry, so that it is available for browsing, download, and querying through NCBI Bioportal web site and application programming interface. The NASA Ames Life Science Data Archive (ALSDA) is also in the process of adopting use of the RBO, taking NASA one step closer to a knowledge-based system for space biology data. It is our hope that the global communities of radiation research Investigators, data curators and data analysts can similarly leverage the RBO and will contribute to its further development.

radiation↗

DOE OSTI2025

Pivotal trial characteristics and types of endpoints used to support Food and Drug Administration rare disease drug approvals between 2013 and 2022

Background/aims Rare disease drug development faces unique challenges, such as genotypic and phenotypic heterogeneity within small patient populations and a lack of established outcome measures for conditions without previously successful drug development programs. These challenges complicate the process of selecting the appropriate trial endpoints and conducting clinical trials in rare diseases. In this descriptive study, we examined novel drug approvals for non-oncologic rare diseases by the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research over the past decade and characterized key regulatory and trial design elements with a focus on the primary efficacy endpoint utilized as the basis of approval. Methods Using the Food and Drug Administration’s Data Analysis Search Host database, we identified novel new drug applications and biologics license applications with orphan drug designation that were approved between 2013 and 2022 for non-oncologic indications. From Food and Drug Administration review documents and other external databases, we examined characteristics of pivotal trials for the included drugs, such as therapeutic area, trial design, and type of primary efficacy endpoints. Differences in trial design elements associated with primary efficacy endpoint type were assessed such as randomization and blinding. Then, we summarized the primary efficacy endpoint types utilized in pivotal trials by therapeutic area, approval pathway, and whether the disease etiology is well defined. Results One hundred and seven drugs that met our inclusion criteria were approved between 2013 and 2022. Assessment of the 107 drug development programs identified 150 pivotal trials that were subsequently analyzed. The pivotal trials were mostly randomized (80%) and blinded (69.3%). Biomarkers (41.1%) and clinical outcomes (42.1%) were commonly utilized as primary efficacy endpoints. Analysis of the use of clinical trial design elements across trials that utilized biomarkers, clinical outcomes, or composite endpoints did not reveal statistically significant differences. The choice of primary efficacy endpoint varied by the drug’s therapeutic area, approval pathway, and whether the indicated disease etiology was well defined. For example, biomarkers were commonly selected as primary efficacy endpoints in hematology drug approvals (70.6%), whereas clinical outcomes were commonly selected in neurology drug approvals (69.6%). Further, if the disease etiology was well defined, biomarkers were more commonly used as primary efficacy endpoints in pivotal trials (44.7%) than if the disease etiology was not well defined (27.3%). Discussion In the past 10 years, numerous novel drugs have been approved to treat non-oncologic rare diseases in various therapeutic areas. To demonstrate their efficacy for regulatory approval, biomarkers and clinical outcomes were commonly utilized as primary efficacy endpoints. Biomarkers were not only frequently used as surrogate efficacy endpoints in accelerated approvals, but also in traditionally approved rare disease drugs. The choice of primary efficacy endpoints varied by therapeutic area, approval pathway, and understanding of disease etiology.

Hong, Kyungwan [Rare Diseases Team, Office of New ↗

NASA NTRS2019

How Do Climate Change Experiments Alter Plot-Scale Climate?

To understand and forecast biological responses to climate change, scientists frequently use field experiments that alter temperature and precipitation. Climate manipulations can manifest in complex ways, however, challenging interpretations of biological responses. We reviewed publications to compile a database of daily plot-scale climate data from 15 active-warming experiments. We find that the common practices of analysing treatments as mean or categorical changes (e.g. warmed vs.unwarmed) masks important variation in treatment effects over space and time. Our synthesis showed that measured mean warming, in plots with the same target warming within a study, differed by up to 1.6° Celsius degrees (63% of target), on average, across six studies with blocked designs. Variation was high across sites and designs: for example, plots differed by 1.1°Celsius degrees (47% of target) on average, for infrared studies with feedback control (n = 3) vs. by 2.2° Celsius degrees (80% of target) on average for infrared with constant wattage designs (n = 2). Warming treatments produce non-temperature effects as well, such as soil drying. The combination of these direct and indirect effects is complex and can have important biological consequences. With a case study of plant phenology across five experiments in our database, we show how accounting for drier soils with warming tripled the estimated sensitivity of budburst to temperature. We provide recommendations for future analyses, experimental design,and data sharing to improve our mechanistic understanding from climate change experiments, and thus their utility to accurately forecast species' responses.

warming experiment↗

NASA NTRS1989

Viking Biology Experiments and the Martian soil

The Viking Biology Experiments (VBE) are the most informative database on the wet chemistry and reactivity of the Martian soil available today. The simulation and chemical interpretation of the results have given valuable hints towards the characterization of the soils' mineralogy, adsorption properties, pH and redox. The characterization of Mars' soil on the basis of ten years of labelled release (LR) and other VBE simulations are reviewed.

Banin, Amos↗

NASA NTRS1997

Biogeochemistry of DMS in Surface Waters

Dimethylsulfide (DMS) is important in influencing the formation of aerosols in the troposphere over large areas of the world's oceans. Understanding the dynamics of aerosols is important to understanding the earth's radiation balance. In evaluating the factors controlling DMS in the troposphere it is vital to understand the dynamics of DMS in the surface ocean. The biogeochemical processes controlling DMS concentration in seawater are myriad; modeling and theoretical estimation are problematic. At the beginning of this project we believed that we were on the verge of simplifying the ship-track measurement of DMS, and we proposed to deploy such a system to develop a database relating high frequency DMS measurements to biological and physicochemical and optical properties of surface water that can be quantified by remote sensing techniques. We designed a system to measure DMS concomitantly with other basic chemical and biological data in a flow-through system. The project was collaborative between Woods Hole Oceanographic Institution (WHOI) and Bermuda Biological Station for Research (BBSR). The project on which we are reporting was budgeted for only one year with a one year no-cost extension. At WHOI our effort was directed towards designing traps which would be used to concentrate DMS from seawater and allow storage for subsequent analysis. At that time, GC systems were too large for easy long-term deployment on a research vessel like R/V Weatherbird, so we focused on simplifying the shipboard sampling procedure. Initial studies of sample recovery with high levels of DMS suggested that Carboxen 1000, a relatively new carbon molecular sieve, could be used as a stable storage medium. The affinity of Carboxen for DMS is several orders of magnitude higher than gold wool (another adsorbent used for DMS collection) on a weight or volume basis. Furthermore, Carboxen's affinity for DMS is also far less susceptible to humidity than gold wool. Unfortunately, further experiments with low level DMS indicated that recovery of DMS after storage was not quantitative. The material has proven to be completely acceptable for short term storage and has been incorporated into a micro-GC system. Since working on this project, we have collaborated with RVM Scientific in Santa Barbara in the design and construction of small portable micro-GC's that will make feasible at-sea measurement in moving ships, making rapid gas analysis and quantification feasible in a ship-track mode. Throughout this period at both WHOI and BBSR, we continued to analyze field data to understand that patterns of time and space variability in DMS and the processes that govern it. These insights will be crucial to determining the specifications for our automated sampling program. The data from this, the longest continuous sampling program for ocean DMS, provided insights into year to year and short-term variability.

Dacey, J. W. H.↗

NASA NTRS2019

NASA GeneLab Space Omics Database: Expanding from Space to Ionizing Radiation Data on the Ground

NASA GeneLab is an open-access repository for omics datasets generated by biological experiments conducted in space or ground experiments relevant to spaceflight (e.g. simulated cosmic radiation, simulated microgravity, bed rest studies). The GeneLab Data Systems (GLDS) version 4.0 will be available on October 1st 2019, and will provide a state-of-the-art bioinformatics platform for the space biology and radiation communities to upload their data into an omics data commons, to process their data with vetted standard workflows and to compare with existing analyses. Started in 2015 as a repository designed to archive omics data from space experiments, GeneLab has expanded its scope to all ionizing radiation omics experiments conducted on the ground and has put considerable effort in providing carefully characterized radiation metadata on all datasets. GeneLab is also providing processed data derived from the raw data covering a large spectrum of omics (genome, epigenome, transcriptome, epitranscriptome, proteome, metabolome) to help users explore important questions: 1) Which genes or proteins are expressed differently in space for various living organisms? 2) What specific DNA mutations or epigenetic changes happen in space or after exposure to ionizing radiation? and 3) How does genetics affect these responses? Processed data available on GeneLab are derived by standard data analysis workflows vetted by hundreds of scientists who volunteered to join one of the four GeneLab Analysis Working Groups (Animal AWG, Plant AWG, Microbe AWG, Multi-Omics AWG). In this presentation, we will discuss how to bridge the gap between irradiation studies performed on earth and biological experiments conducted in space since the early 1990's. We will discuss how radiation dosimetry was estimated for datasets derived from samples collected during the Space Shuttle era on the International Space Station and on other orbiting platforms. Finally, we will address future strategies regarding dose monitoring in future missions into space, inter-agency efforts to unify data under one umbrella, and knowledge dissemination across the radiation research community and the space biology community.

open-science↗

NASA NTRS2021

Knowledge Network Embedding of Transcriptomic Data From Spaceflown Mice Uncovers Signs and Symptoms Associated With Terrestrial Diseases

There has long been an interest in understanding how the hazards from spaceflight may trigger or exacerbate human diseases. With the goal of advancing our knowledge on physiological changes during space travel, NASA GeneLab provides an open-source repository of multi-omics data from real and simulated spaceflight studies. Alone, this data enables identification of biological changes during spaceflight, but cannot infer how that may impact an astronaut at the phenotypic level. To bridge this gap, SPOKE, a heterogeneous knowledge graph connecting biological and clinical data from over 30 databases, was used in combination with GeneLab transcriptomic data from six studies. This integration identified critical symptoms and physiological changes incurred during spaceflight.

spaceflight↗

NASA NTRSDate not supplied

Introduction of the NASA Microgravity Research Library

As opportunities for conducting experiments in space are rare, more studies have been published using ground-based analogs that simulate microgravity conditions. For example, when conducting a literature search in PubMed for peer-reviewed articles and studies that used simulated microgravity conditions, results will yield over 5,000 publications dating back to 1961. The issue with this search technique and medium is that these articles are vast in quantity and spread out across multiple web-based databases, repositories, and libraries; some of which, are wholly inaccessible. For example, in PubMed for a single year, we found 1,000+ microgravity research articles among more than 12,000 general, space research articles; these, were within an overarching 350,000+ total, general medical research articles for just 2020. The KSC Microgravity Simulation Support Facility (MSSF), with support from the KSC Information Technology (IT) Applications Development Team and the NASA Space Biology Program, took the initiative to develop a database that would serve as the central repository for existing microgravity research. This repository site is open to the public and houses not only peer-reviewed publications relating to microgravity research, but also dissertations, technical publications such as white papers, NASA technical publications, and patent publications. In this presentation, we will discuss some of our literature research findings as well as present a working prototype version of the Library. It is our goal that the future infrastructure of this database advance to become a fully-functional, NASA Space Life-Sciences Research Library.

Anna Maria Ruby↗

NASA NTRSDate not supplied

Introduction of the NASA Microgravity Research Library

Anna Maria Ruby↗

NASA NTRSDate not supplied

Open Science for Omics and Space Biological Data at NASA

Explore the source record for details and available documents.

Database↗

NASA NTRSDate not supplied

NASA GeneLab: Open Science for Life in Space

The NASA GeneLab project (genelab.nasa.gov) seeks to get the most from space-relevant biology experiments by providing and maintaining a public database consisting of DNA, RNA, protein, and metabolite data from spaceflight experiments. Since these types of data, referred to as omics data, are difficult to understand for non-bioinformaticians, the GeneLab data processing team works with the scientific community to develop methods to process these data. The processed data found on GeneLab reveals information about which genes are turned on and turned off in the space environment, which helps us understand how space changes our biology and how we can best mitigate these effects to travel deeper into space.

Jonathan Oribello↗

NASA NTRS2006

A Bioinformatics Facility for NASA

Building on an existing prototype, we have fielded a facility with bioinformatics technologies that will help NASA meet its unique requirements for biological research. This facility consists of a cluster of computers capable of performing computationally intensive tasks, software tools, databases and knowledge management systems. Novel computational technologies for analyzing and integrating new biological data and already existing knowledge have been developed. With continued development and support, the facility will fulfill strategic NASA s bioinformatics needs in astrobiology and space exploration. . As a demonstration of these capabilities, we will present a detailed analysis of how spaceflight factors impact gene expression in the liver and kidney for mice flown aboard shuttle flight STS-108. We have found that many genes involved in signal transduction, cell cycle, and development respond to changes in microgravity, but that most metabolic pathways appear unchanged.

Schweighofer, Karl↗

NASA NTRS2004

Monitoring the Mesoamerican Biological Corridor: A NASA/CCAD Cooperative Research Project

To foster scientific cooperation under a Memorandum of Understanding between NASA and the Central American countries, the research project developed regional databases to monitor forest condition and environmental change throughout the region. Of particular interest is the Mesoamerican Biological Corridor (MBC), a chain of protected areas and proposed conservation areas that will link segments of natural habitats in Central America from the borders of northern Columbia to southern Mexico. The first and second year of the project focused on the development of regional satellite databases (JERS-IC, MODIS, and Landsat-TM), training of Central American cooperators and forest cover and change analysis. The three regional satellite mosaics were developed and distributed on CD-ROM to cooperators and regional outlets. Four regional remote sensing training courses were conducted in 3 countries including participants from all 7 Central American countries and Mexico. In year 3, regional forest change assessment in reference to Mesoamerican Biological Corridor was completed and land cover maps (from Landsat TM) were developed for 7 Landsat scenes and accuracy assessed. These maps are being used to support validation of MODIS forest/non forest maps and to examine forest fragmentation and forest cover change in selected study sites. A no-cost time extension (2003-2004) allowed the completion of an M.S. thesis by a Costa Rican student and preparation of manuscripts for future submission to peer-reviewed outlets. Proposals initiated at the end of the project have generated external funding from the U.S. Forest Service (to U. Maine), NASA-ESSF (Oregon State U.) and from USAID and EPA (to NASA-MSFC-GHCC) to test MODIS capabilities to detect forest change; conduct literature review on biomass estimation and carbon stocks and develop a regional remote sensing monitoring center in Central America. The success of the project has led to continued cooperation between NASA, other federal agencies, and scientists from all seven Central American Countries (see SERVIR web site for this ongoing work - servir.nsstc.nasa.gov).

Sever, Thomas↗

NASA NTRS2019

GeneLab: A Systems Biology Platform for Omics Analysis

NASA's GeneLab includes an open-access repository of some 200+ omics datasets generated by biological experiments relevant to spaceflight (including simulated cosmic radiation and microgravity). In order to maximize the intelligibility of these data, particularly for users with limited bioinformatics knowledge, GeneLab is now transforming the data in the repository into actual biological and physiological knowledge of the genetic and proteomic signatures found in these samples. This processed data is being derived by establishing standard data analysis workflows vetted by 114 scientists who are members of the four GeneLab Analysis Working Groups (Animal AWG, Plant AWG, Microbe AWG, Multi-Omics AWG). AWG members from institutes spanning the U.S. and four other countries participate on a voluntary basis. The AWGs meet monthly to discuss data mining, compare results and interpretations, and test forthcoming releases of the GeneLab Data Systems (GLDS). GLDS version 3.0 has been available to the general public since October 1st 2018, and has been providing a professional state-of-the-art bioinformatics platform for everyone in the space biology community to upload their data into a space biology omics data commons, to process their data with vetted standard workflows and to compare to existing analyses. The user interface for the platform is being designed to be accessible to a broad variety of users including those with limited bioinformatics experience, including high school and college students who can use it to learn about omics data analysis and space biology. As such, Genelab will constitute a powerful general public outreach capability of NASA and the Space Biology community at large. Data mining of the GeneLab database by the AWG has already started generating very interesting findings, including reports linking specific spaceflight conditions such as radiation, microgravity or carbon dioxide levels to molecular changes seen across various species. In this presentation, we will report on the current and future objectives for GeneLab, and review recent studies reported by the various AWGs relating molecular changes observed in various animal models and tissue with microgravity, radiation, circadian rhythm, hydration and carbon dioxide conditions.

Omics↗

NASA NTRS2019

GeneLab: A Systems Biology Platform for Omics Analysis: Disseminate and Reuse Data, Tools, and Samples Post-Project

NASA's GeneLab includes an open-access repository of some 200 plus omics datasets generated by biological experiments relevant to spaceflight (including simulated cosmic radiation and microgravity). In order to maximize the intelligibility of these data, particularly for users with limited bioinformatics knowledge, GeneLab is now transforming the data in the repository into actual biological and physiological knowledge of the genetic and proteomic signatures found in these samples. This processed data is being derived by establishing standard data analysis workflows vetted by 114 scientists who are members of the four GeneLab Analysis Working Groups (Animal AWG, Plant AWG, Microbe AWG, Multi-Omics AWG). AWG members from institutes spanning the U.S. and four other countries participate on a voluntary basis. The AWGs meet monthly to discuss data mining, compare results and interpretations, and test forthcoming releases of the GeneLab Data Systems (GLDS). GLDS version 3.0 has been available to the general public since October 1st 2018, and has been providing a professional state-of-the-art bioinformatics platform for everyone in the space biology community to upload their data into a space biology omics data commons, to process their data with vetted standard workflows and to compare to existing analyses. The user interface for the platform is being designed to be accessible to a broad variety of users including those with limited bioinformatics experience, including high school and college students who can use it to learn about omics data analysis and space biology. As such, Genelab will constitute a powerful general public outreach capability of NASA and the Space Biology community at large. Data mining of the GeneLab database by the AWG has already started generating very interesting findings, including reports linking specific spaceflight conditions such as radiation, microgravity or carbon dioxide levels to molecular changes seen across various species. In this presentation, we will report on the current and future objectives for GeneLab, and review recent studies reported by the various AWGs relating molecular changes observed in various animal models and tissue with microgravity, radiation, circadian rhythm, hydration and carbon dioxide conditions.

Omics↗